{"id":2798,"date":"2017-08-04T17:02:15","date_gmt":"2017-08-04T21:02:15","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=2798"},"modified":"2017-08-04T17:03:18","modified_gmt":"2017-08-04T21:03:18","slug":"ipo-weekly-recap-small-in-quantity-size-in-gains","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/ipo-weekly-recap-small-in-quantity-size-in-gains\/","title":{"rendered":"IPO Weekly Recap: Small in quantity, size in gains"},"content":{"rendered":"

It was another light week in the IPO market as just two IPOs came to market but both performed well in their respective debuts. <\/span><\/p>\n

\"Screen<\/a><\/p>\n

\"Clementia<\/a>
Clementia Pharmaceuticals (PRNewsFoto\/Clementia Pharmaceuticals, Inc.)<\/figcaption><\/figure>\n

Clementia Pharmaceuticals (Nasdaq: CMTA) <\/b>priced at the high-end of its range, $15.00, and opened at $18.25 for a 21.7% gain at first trade. \u2018CMTA\u2019 hit a first week high of $18.95 before curtailing gains and at the time of this writing, it was trading close to its IPO price to end the week. IPO Boutique clients were tuned into the strength of this deal from the beginning. Demand in the deal was evident and IPO Boutique upgraded the rating from a ‘3’ to a ‘4’. Below are the messages that IPO Boutique client received throughout the week to help guide the indication process for the ‘CMTA’ IPO.\u00a0<\/span><\/p>\n

\"ClementiaPharmaAdvisories\"<\/a><\/p>\n

\"download\"<\/a><\/p>\n

The other deal this week, <\/span>Venator Materials plc (NYSE: VNTR), <\/b>priced at the low-end of the range, $20.00, and opened $0.89 higher for a 4.5% gain at first strade. \u2018VNTR\u2019 traded well in its first day as a public company as the chemical company hit a first day high of $21.34. Venator Materials traded consistent and closed the week at $20.63.<\/span><\/p>\n

Looking ahead to this week\u2026 there are three\u00a0IPOs on the schedule. Click here to look at the schedule for the upcoming week.<\/a><\/strong><\/p>\n

\n

IPO BOUTIQUE for your Syndicate Needs!<\/strong><\/p>\n

\n
What if you could take the guess work out of trading the syndicate calendar? Or what if you indicated for deals with the knowledge that large institutional funds are in the deal also?<\/div>\n
<\/div>\n
IPO Boutique\u2019s vast network of underwriter contacts and sources can do just that! On the IPO side, it means research & daily color in conjunction with 45 years of IPO experience. For secondaries, our highest-level of client receives Alerts on all offering, re-offer ranges, ratings and color for any deal that is marketed more than an overnight-offering.<\/div>\n
<\/div>\n
If you indicate for IPOs or Secondary Offerings on a regular basis \u2014 place IPO Boutique on your team. Subscribe Today!<\/a><\/strong><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"

It was another light week in the IPO market as just two IPOs came to market but both performed well in their respective debuts. Clementia Pharmaceuticals (Nasdaq: CMTA) priced at the high-end of its range, $15.00, and opened at $18.25 for a 21.7% gain at first trade. \u2018CMTA\u2019 hit a first week high of $18.95[…]<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[24,141],"tags":[],"class_list":["post-2798","post","type-post","status-publish","format-standard","hentry","category-ipo","category-weekly-recap"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2798","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=2798"}],"version-history":[{"count":2,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2798\/revisions"}],"predecessor-version":[{"id":2802,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/2798\/revisions\/2802"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=2798"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=2798"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=2798"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}